Cwm LLC lessened its stake in MetLife, Inc. (NYSE:MET – Free Report) by 2.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,432 shares of the financial services provider’s stock after selling 671 shares during the period. Cwm LLC’s holdings in MetLife were worth $1,884,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Kathmere Capital Management LLC grew its stake in shares of MetLife by 88.2% during the second quarter. Kathmere Capital Management LLC now owns 6,328 shares of the financial services provider’s stock worth $509,000 after acquiring an additional 2,965 shares during the last quarter. First Horizon Advisors Inc. grew its stake in shares of MetLife by 4.8% during the first quarter. First Horizon Advisors Inc. now owns 422,684 shares of the financial services provider’s stock worth $33,937,000 after acquiring an additional 19,192 shares during the last quarter. Pinnacle Financial Partners Inc purchased a new stake in shares of MetLife during the first quarter worth about $255,000. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of MetLife by 20.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 60,785 shares of the financial services provider’s stock worth $4,735,000 after acquiring an additional 10,414 shares during the last quarter. Finally, Heartland Bank & Trust Co purchased a new stake in shares of MetLife during the first quarter worth about $516,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on MET shares. JPMorgan Chase & Co. boosted their price target on MetLife from $86.00 to $95.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 8th. Morgan Stanley lifted their target price on MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Barclays lifted their target price on MetLife from $93.00 to $98.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of MetLife in a report on Wednesday, October 8th. Finally, Piper Sandler downgraded MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 target price for the company. in a report on Friday, September 19th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $95.18.
MetLife Stock Up 0.9%
MetLife stock opened at $78.55 on Monday. The stock has a market capitalization of $52.24 billion, a PE ratio of 13.31, a price-to-earnings-growth ratio of 0.71 and a beta of 0.86. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The business has a 50 day simple moving average of $80.20 and a 200-day simple moving average of $78.10. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts’ consensus estimates of $2.32 by ($0.30). MetLife had a net margin of 5.83% and a return on equity of 19.88%. The business had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $18.58 billion. During the same quarter last year, the firm earned $2.28 earnings per share. The firm’s quarterly revenue was down 2.7% compared to the same quarter last year. On average, analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current fiscal year.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 4th will be issued a $0.5675 dividend. This represents a $2.27 annualized dividend and a yield of 2.9%. The ex-dividend date is Tuesday, November 4th. MetLife’s dividend payout ratio is presently 38.47%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Where Do I Find 52-Week Highs and Lows?
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- Large Cap Stock Definition and How to Invest
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- What is a Death Cross in Stocks?
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.